Lifecare ASA is a Norway-based company that develops miniaturized and implantable nanobiosensors for correct and continuous monitoring of glucose and other biomarkers. Lifecare's activities are concentrated on the development of sensor for use as a medical product, initially the sensor Sencell for continuous monitoring of glucose (blood sugar) for people with diabetes. The technology is suitable for detecting and measuring a wide range of molecules that can occur in the human body, based on variations in osmotic pressure.

Employees

Sector

Biotechnology & Medical Research

Calendar

11-12 Earnings release - Q3 2026

More about the company

Market Cap	116M 12.38M 10.72M 10.14M 9.18M 17.23M 1.19B 17.36M 121M 46.55M 602M 46.5M 45.47M 1.92B	P/E 2026 *	-0.81x	P/E 2027 *	-1.77x
Enterprise Value	107M 11.41M 9.89M 9.35M 8.46M 15.89M 1.09B 16.01M 112M 42.93M 555M 42.88M 41.93M 1.77B	EV / Sales 2026 *	107x	EV / Sales 2027 *	-
Free-Float	65.56%	Yield 2026 *	-	Yield 2027 *	-

09-14	Lifecare Completes Acquisition of 87% Stake in Ocean TuniCell	MT
09-11	Lifecare ASA (OB:LIFE) acquired 86.7% stake in Ocean Tunicell AS from Captured AS.	CI
08-31	Ocean GeoLoop Subsidiary to Sell Ocean Tunicell Stake to Lifecare	MT
08-19	Lifecare ASA Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-19	Lifecare ASA, Q2 2026 Earnings Call, Aug 19, 2026
07-02	Lifecare Completes Production Transfer and Provides Update on Longevity Programme	CI
06-29	Lifecare Transfers Operations from Germany to Norway, UK	MT
06-27	Lifecare ASA Discontinues Operations of Lifecare Germany GmbH	CI
06-19	An undisclosed buyer signed a non-binding agreement to acquire Ocean Tunicell AS from Ocean GeoLoop AS (OB:OCEAN).	CI
06-10	Lifecare Completes First Six-Month Implant Evaluation With Continued Functionality and No Adverse Biological Response	CI
05-15	Lifecare ASA, Q1 2026 Earnings Call, May 15, 2026
05-15	Lifecare ASA Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
05-15	Lifecare Q1 operating loss NOK 31.5 mln	RE

08-19	Lifecare : Interim Report Q2 2026 Presentation	PU
08-19	LIFE: Lifecare ASA Q2 2026 results	PU
08-12	Lifecare ASA (LIFE): Invitation to presentation of Q2 2026 results 19 August at 08.45 CEST	AQ
07-02	LIFE: Update on production transfer and longevity programme	AQ
06-26	LIFE: Operational update regarding Lifecare Germany GmbH (i.L)	PU

Manager	Title	Age	Since
Joacim Holter CEO	Chief Executive Officer	50	07/09/2020
Petter Nielsen DFI	Director of Finance/CFO	-	01/04/2026
Torsten Ernst PRN	Corporate Officer/Principal	-	01/03/2024

Director	Title	Age	Since
Trine Teigland BRD	Director/Board Member	-	26/06/2020
Morten Foros Krohnstad CHM	Chairman	-	08/05/2021
Lutz Heinemann BRD	Director/Board Member	-	20/11/2020

Lifecare AS Stock Oslo Bors

Stocks

NO0010591191

Biotechnology & Medical Research

Valuation: Lifecare AS

Latest news: Lifecare AS

Last Transcript: Lifecare AS

Analysts' recommendations: Lifecare AS

Press Releases: Lifecare AS

News in other languages: Lifecare AS

Managers and Directors: Lifecare AS

Other Biotechnology & Medical Research

Financials

Company Profile

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
LIFECARE AS	-.--%	-4.31%	-	-	12.4M
LONZA GROUP AG	+0.56%	-3.38%	-1.83%	+8.00%	45.63B
REVOLUTION MEDICINES, INC.	-0.72%	-1.75%	+340.91%	+541.37%	43.96B
IQVIA HOLDINGS INC.	+1.60%	+4.30%	+45.37%	+27.70%	43.73B
BEONE MEDICINES AG	-1.51%	-0.81%	+4.93%	+74.04%	40.23B
CELLTRION, INC.	-0.73%	-4.72%	+8.55%	+37.89%	31.86B
ASCENDIS PHARMA A/S	-11.10%	-12.80%	-	-	17.4B
MEDPACE HOLDINGS, INC.	+4.06%	+4.73%	+24.66%	+121.03%	16.62B
EUROFINS SCIENTIFIC SE	+1.83%	+3.20%	+16.49%	+32.73%	14.46B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	+0.42%	-2.20%	+80.37%	+32.09%	13.04B
Average	-0.59%	-1.81%	+64.93%	+109.36%	29.66B
Weighted average by Cap.	-0.46%	-2.09%	+76.36%	+130.11%

	2026 *	2027 *
Net sales	1M 107K 92.77K 87.72K 79.41K 149K 10.27M 150K 1.05M 403K 5.21M 402K 393K 16.61M	-
Net income	-109M -11.67M -10.11M -9.56M -8.66M -16.25M -1.12B -16.37M -114M -43.9M -568M -43.85M -42.88M -1.81B	-67M -7.18M -6.22M -5.88M -5.32M -9.99M -688M -10.06M -70.13M -26.98M -349M -26.95M -26.35M -1.11B
Net Debt	-9M -964K -835K -789K -715K -1.34M -92.46M -1.35M -9.42M -3.62M -46.88M -3.62M -3.54M -150M	4M 428K 371K 351K 318K 596K 41.09M 601K 4.19M 1.61M 20.84M 1.61M 1.57M 66.45M